Decision 50/28

Following the discussion, the Executive Committee decided to approve the project for the phase-out of CFC consumption in the manufacture of metered-dose inhalers in Egypt, at a total cost of US $5,899,000 plus agency support costs of US $442,425 for UNIDO, as follows:

1. To approve the national strategy for the phase-out of CFC-based metered-dose inhalers for Egypt at the amount of US $99,000 plus agency support costs for UNIDO;
2. To approve the conversion of the two metered-dose inhaler manufacturing plants in Egypt at the amount of US $1,900,000 plus agency support costs for UNIDO;
3. To approve technology transfer at the amount of US $3 million plus agency support costs for UNIDO, on the understanding that UNIDO would negotiate with potential providers prior to the 52^nd Meeting of the Executive Committee and that any savings that might be realized during the process would be returned to the Multilateral Fund at the 52^nd Meeting of the Executive Committee; and
4. To approve total incremental operating costs at the amount of US $900,000 plus agency support costs for UNIDO.